IndraLab

Statements


3 | 2 1

No evidence text available

sparser
"This study suggests that targeting of the USP3-COL9A3 or USP3-COL6A5 axis could be developed as a therapeutic strategy for GC management."

reach
"For instance, USP3 can bind and deubiquitinate COL9A3/COL6A5 to facilitate gastric cancer cell migration and progression (Wu et al. 2021)."

No evidence text available

No evidence text available

reach
"Mechanistically, we observed that USP3 interacted with and stabilised COL9A3 and COL6A5 via deubiquitination in GC."